My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 96

    1.

    Inhibition of Poly(ADP-ribose)polymerase impairs Epstein Barr Virus lytic cycle progression.

    Mattiussi S, Tempera I, Matusali G, Mearini G, Lenti L, Fratarcangeli S, Mosca L, D'Erme M, Mattia E.

    Infect Agent Cancer. 2007 Oct 11;2:18.PMID: 17931416 [PubMed - in process]Related articlesFree article

    2.

    Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replication.

    Kudoh A, Daikoku T, Sugaya Y, Isomura H, Fujita M, Kiyono T, Nishiyama Y, Tsurumi T.

    J Virol. 2004 Jan;78(1):104-15.PMID: 14671092 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Inhibition of p38 MAP kinase pathway induces apoptosis and prevents Epstein Barr virus reactivation in Raji cells exposed to lytic cycle inducing compounds.

    Matusali G, Arena G, De Leo A, Di Renzo L, Mattia E.

    Mol Cancer. 2009 Mar 9;8:18.PMID: 19272151 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    hTERT inhibits the Epstein-Barr virus lytic cycle and promotes the proliferation of primary B lymphocytes: implications for EBV-driven lymphomagenesis.

    Terrin L, Dolcetti R, Corradini I, Indraccolo S, Col JD, Bertorelle R, Bonaldi L, Esposito G, De Rossi A.

    Int J Cancer. 2007 Aug 1;121(3):576-87.PMID: 17417773 [PubMed - indexed for MEDLINE]Related articles

    6.

    One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection.

    Kubota N, Wada K, Ito Y, Shimoyama Y, Nakamura S, Nishiyama Y, Kimura H.

    J Virol Methods. 2008 Jan;147(1):26-36. Epub 2007 Sep 17.PMID: 17870188 [PubMed - indexed for MEDLINE]Related articles

    7.

    Regulation of cellular and viral protein expression by the Epstein-Barr virus transcriptional regulator Zta: implications for therapy of EBV associated tumors.

    Chen C, Li D, Guo N.

    Cancer Biol Ther. 2009 Jun;8(11):987-95. Epub 2009 Jun 10. Review.PMID: 19448399 [PubMed - indexed for MEDLINE]Related articles

    8.

    Quantitative evaluation of the role of Epstein-Barr virus immediate-early protein BZLF1 in B-cell transformation.

    Katsumura KR, Maruo S, Wu Y, Kanda T, Takada K.

    J Gen Virol. 2009 Oct;90(Pt 10):2331-41. Epub 2009 Jun 24.PMID: 19553389 [PubMed - indexed for MEDLINE]Related articles

    9.

    Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle.

    Croft NP, Shannon-Lowe C, Bell AI, Horst D, Kremmer E, Ressing ME, Wiertz EJ, Middeldorp JM, Rowe M, Rickinson AB, Hislop AD.

    PLoS Pathog. 2009 Jun;5(6):e1000490. Epub 2009 Jun 26.PMID: 19557156 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A.

    Seo JS, Cho NY, Kim HR, Tsurumi T, Jang YS, Lee WK, Lee SK.

    Oncol Rep. 2008 Jan;19(1):93-8.PMID: 18097580 [PubMed - indexed for MEDLINE]Related articles

    11.

    Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase.

    Hagemeier SR, Dickerson SJ, Meng Q, Yu X, Mertz JE, Kenney SC.

    J Virol. 2010 Feb 24. [Epub ahead of print]PMID: 20181712 [PubMed - as supplied by publisher]Related articles

    12.

    Hypoxia can contribute to the induction of the Epstein-Barr virus (EBV) lytic cycle.

    Jiang JH, Wang N, Li A, Liao WT, Pan ZG, Mai SJ, Li DJ, Zeng MS, Wen JM, Zeng YX.

    J Clin Virol. 2006 Oct;37(2):98-103. Epub 2006 Aug 22.PMID: 16931136 [PubMed - indexed for MEDLINE]Related articles

    13.

    Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.

    Niller HH, Wolf H, Minarovits J.

    Autoimmunity. 2008 May;41(4):298-328. Review.PMID: 18432410 [PubMed - indexed for MEDLINE]Related articles

    14.

    ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus.

    Yu X, Wang Z, Mertz JE.

    PLoS Pathog. 2007 Dec;3(12):e194.PMID: 18085824 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Stimulus duration and response time independently influence the kinetics of lytic cycle reactivation of Epstein-Barr virus.

    Countryman J, Gradoville L, Bhaduri-McIntosh S, Ye J, Heston L, Himmelfarb S, Shedd D, Miller G.

    J Virol. 2009 Oct;83(20):10694-709. Epub 2009 Aug 5.PMID: 19656890 [PubMed - indexed for MEDLINE]Related articles

    16.

    Molecular basis of cytotoxicity of Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) in EBV latency III B cells: LMP1 induces type II ligand-independent autoactivation of CD95/Fas with caspase 8-mediated apoptosis.

    Le Clorennec C, Ouk TS, Youlyouz-Marfak I, Panteix S, Martin CC, Rastelli J, Adriaenssens E, Zimber-Strobl U, Coll J, Feuillard J, Jayat-Vignoles C.

    J Virol. 2008 Jul;82(13):6721-33. Epub 2008 Apr 30.PMID: 18448526 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Interleukin-21 regulates expression of key Epstein-Barr virus oncoproteins, EBNA2 and LMP1, in infected human B cells.

    Konforte D, Simard N, Paige CJ.

    Virology. 2008 Apr 25;374(1):100-13. Epub 2008 Jan 28.PMID: 18222514 [PubMed - indexed for MEDLINE]Related articles

    18.

    Roles of inhibitors of poly(ADP-ribose) polymerase in protecting rat RINm5F cell line against free fatty acid-induced apoptosis.

    Mao X, Wang S, Pan Y, He B, Chen J, Jiang H, Zeng Q, Xu X.

    Exp Clin Endocrinol Diabetes. 2009 Jun;117(6):274-82. Epub 2009 Jun 9.PMID: 19513971 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Effects of Epstein-Barr virus on host gene expression in Burkitt's lymphoma cell lines.]

    Broderick P, Hubank M, Sinclair A.

    Chinese journal of cancer. 2009 Aug;28(8):813-21. Chinese. PMID: 19664326 [PubMed - in process]Related articlesFree article

    20.

    Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.

    Ressing ME, Horst D, Griffin BD, Tellam J, Zuo J, Khanna R, Rowe M, Wiertz EJ.

    Semin Cancer Biol. 2008 Dec;18(6):397-408. Epub 2008 Oct 25. Review.PMID: 18977445 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk